Because of such an important events and the venue is in Singapore, we were hoping that many participants from Indonesia will come to the PAG Asia 2013 conference. Unfortunately, that was not the case at all. We did not see many participants from Indonesia attending the PAG Asia conference in Singapore. None representing BB Biogen, where the initiative of genome sequencing activities been done since 2012. Neither representing LIPI, BPTP, nor from others prestigious research centers and institutes from Indonesia, nor from a number of top universities in Indonesia came to PAG Asia 2013.
There only seven participants having association with Indonesia. Two of them were representatives of private companies (East West Seed Indonesia – an Indonesian Company and Orion Genomic – a USA company). The other two were Indonesian graduate students pursuing higher degrees in South Korea and USA, respectively and one is representative of International Rice Research Institute (IRRI, Dr. Inez Hortense Slamet Loedin). The last two participants were from Indonesian Palm Research Institute (Balit Palma, Manado – Ir. Ismail Maskromo, MS.) and from PMB Lab, Department of Agronomy and Horticulture, Faculty of Agriculture, Bogor Agricultural University (IPB – Prof. Sudarsono), respectively. Currently, Ismail Maskromo is pursuing his PhD degree at IPB and conducting his PhD dissertation research at PMB Lab.
There was a surprising and positive news from the PAG Asia 2013 conference, one of the biotech company (Formulatrix) participating as exhibitor in the conferences was actually a biotech company located in Salatiga, Central Java. The company is a manufacturer of a robotic device that can automatically dispense solutions into small tubes. We are surprised to learn and we have no idea that there is such a biotech company in Indonesia. It was an interesting information to learn from such a conference.
PMB Lab staff and associated graduate student are proud that two representative of this lab have been able to come to the meeting and learned the state of the art progress in genomic research and technologies. We hope that the two representatives could learn and bring some useful information back to PMB Lab specifically and to IPB in general.